Published in Endocrinology on July 01, 1999
Tuberoinfundibular Peptide of 39 residues is required for germ cell development. Endocrinology (2008) 1.55
Distribution of tuberoinfundibular peptide of 39 residues and its receptor, parathyroid hormone 2 receptor, in the mouse brain. J Comp Neurol (2007) 1.18
Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci U S A (2002) 1.14
The TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms. Prog Neurobiol (2009) 0.99
Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience (2009) 0.96
Regulation of hypothalamic signaling by tuberoinfundibular peptide of 39 residues is critical for the response to cold: a novel peptidergic mechanism of thermoregulation. J Neurosci (2011) 0.94
Postnatal development and gender-dependent expression of TIP39 in the rat brain. J Comp Neurol (2006) 0.91
Development of a rat parathyroid hormone 2 receptor antagonist. Peptides (2007) 0.89
TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation. Am J Physiol Endocrinol Metab (2009) 0.85
Evolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish development. J Endocrinol (2011) 0.83
Tuberoinfundibular peptide of 39 residues (TIP39) signaling modulates acute and tonic nociception. Exp Neurol (2010) 0.83
Parathyroid hormone 2 receptor is a functional marker of nociceptive myelinated fibers responsible for neuropathic pain. J Neurochem (2009) 0.79
Model of the complex of Parathyroid hormone-2 receptor and Tuberoinfundibular peptide of 39 residues. BMC Res Notes (2010) 0.78
The neuroendocrine functions of the parathyroid hormone 2 receptor. Front Endocrinol (Lausanne) (2012) 0.78
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis. Clin Interv Aging (2007) 0.78
Breakpoint mapping by whole genome sequencing identifies PTH2R gene disruption in a patient with midline craniosynostosis and a de novo balanced chromosomal rearrangement. J Med Genet (2015) 0.77
Evolution of parathyroid hormone receptor family and their ligands in vertebrate. Front Endocrinol (Lausanne) (2015) 0.77
Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries. Osteoporos Int (2016) 0.75
Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science (2000) 6.16
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci U S A (1997) 3.59
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A (1999) 3.54
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology (1978) 3.21
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol (2000) 2.83
Assessment of aldehyde dehydrogenase in viable cells. Blood (1995) 2.77
Home birth in New Zealand 1973-93: incidence and mortality. N Z Med J (1997) 2.38
Crystal structure of DMSO reductase: redox-linked changes in molybdopterin coordination. Science (1996) 2.35
Sampling variability on percutaneous liver biopsy. Arch Intern Med (1979) 2.12
Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol Psychiatry (1998) 2.12
Cloning of a serotonin transporter affected by antidepressants. Science (1991) 2.12
Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem (1996) 2.11
Minimal anatomical disruption in stoma formation: the lateral rectus abdominis positioned stoma (LRAPS). Colorectal Dis (2010) 2.09
Aging and ethanol metabolism. Clin Pharmacol Ther (1977) 1.99
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood (1990) 1.88
Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood (1996) 1.76
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology (1993) 1.68
Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet (1997) 1.65
Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett (1986) 1.62
Graft-versus-myeloma effect: proof of principle. Blood (1996) 1.58
Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. Biochem Pharmacol (1988) 1.56
Comparison of culture and microscopy in the diagnosis of Gardnerella vaginalis infection. J Clin Pathol (1982) 1.50
APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry (2005) 1.49
Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology. Urology (1999) 1.49
TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci (1999) 1.49
Vasopressin and oxytocin mRNAs in adrenalectomized and Brattleboro rats: analysis by quantitative in situ hybridization histochemistry. Brain Res (1986) 1.47
More rapid elimination of alcohol in women as compared to their male siblings. Alcohol Clin Exp Res (1989) 1.47
Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology (1994) 1.43
Stress and ethanol metabolism. Alcohol Alcohol (1998) 1.42
Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res (1988) 1.39
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res (1984) 1.39
Trauma in cirrhosis: an indicator of the pattern of alcohol abuse in different societies. Alcohol Clin Exp Res (1991) 1.38
[Kinetic analysis of the effects of pentobarbital on rats]. Boll Soc Ital Biol Sper (1966) 1.37
Quantitative histological analysis of the cerebellar nuclei in the cat. I. Numerical data on cells and on synapses. Exp Brain Res (1977) 1.37
Intestinal malabsorption in folate-deficient alcoholics. Gastroenterology (1973) 1.33
Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A (1998) 1.31
Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci U S A (1995) 1.31
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood (1995) 1.30
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience (1998) 1.28
Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun (1998) 1.28
A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.27
Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Res (1987) 1.24
Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab (1997) 1.24
Substance P receptor expression in intestinal epithelium in clostridium difficile toxin A enteritis in rats. Am J Physiol (1998) 1.21
Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nat Med (1998) 1.21
Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol (1998) 1.20
Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol (1986) 1.19
The frequency of transcriptional and translational errors at nonsense codons in the lacZ gene of Escherichia coli. Mol Gen Genet (1983) 1.18
The upstream stimulatory factor binds to and activates the promoter of the rat class I alcohol dehydrogenase gene. J Biol Chem (1991) 1.17
Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week. Pharmacol Res Commun (1978) 1.16
Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology (1996) 1.15
Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett (1989) 1.15
Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids. J Med Chem (1987) 1.15
Cloning of the cocaine-sensitive bovine dopamine transporter. Proc Natl Acad Sci U S A (1991) 1.15
Pancreatic function and intestinal absorption in chronic alcoholism. Gastroenterology (1970) 1.14
Innervation of the nucleus of the solitary tract and the dorsal vagal nucleus by thyrotropin-releasing hormone-containing raphe neurons. Brain Res (1986) 1.14
Distribution of ethanol in the human gastrointestinal tract. Am J Clin Nutr (1973) 1.13
Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci U S A (1984) 1.12
Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes. Endocrinology (1999) 1.11
Junctional care: the key to prevention of catheter sepsis in intravenous feeding. JPEN J Parenter Enteral Nutr (1987) 1.11
Praja1, a novel gene encoding a RING-H2 motif in mouse development. Oncogene (1997) 1.10
Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J Biol Chem (1999) 1.10
Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res (1990) 1.10
Insulin growth factor I and hypogonadism in cirrhosis. Hepatology (2000) 1.08
Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol (1988) 1.08
Serotonin transporter messenger RNA in the developing rat brain: early expression in serotonergic neurons and transient expression in non-serotonergic neurons. Neuroscience (1998) 1.08
Vitamin E and porphyrin metabolism in man. Arch Intern Med (1971) 1.08
Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. Neuroendocrinology (1987) 1.08
Activity of the beta-retinoic acid receptor promoter in transgenic mice. Mech Dev (1991) 1.08
Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg (2000) 1.06
Sex difference in alcohol-related organ injury. Alcohol Clin Exp Res (2001) 1.06
Dispersed donor salivary gland cells are widely distributed in the recipient gland when infused up the ductal tree. Biotech Histochem (2009) 1.05
Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab (1998) 1.05
Rates of ethanol clearance and activities of the ethanol-oxidizing enzymes in chronic alcoholic patients. Gastroenterology (1971) 1.04
Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res (1994) 1.04
Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine (Baltimore) (1977) 1.03
Distribution of parathyroid hormone-2 receptor-like immunoreactivity and messenger RNA in the rat nervous system. Neuroscience (2000) 1.03
Effect of ethanol administration on hepatic ethanol and drug-metabolizing enzymes and on rates of ethanol degradation. J Lab Clin Med (1971) 1.03
Decreased jejunal uptake of labeled folic acid ( 3 H-PGA) in alcoholic patients: roles of alcohol and nutrition. N Engl J Med (1971) 1.03
The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide. Prog Clin Biol Res (1989) 1.02
Use of positron emission tomography to study AT1 receptor regulation in vivo. J Am Soc Nephrol (2001) 1.02
Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene. Neuron (1993) 1.02
Pharmacokinetic profile of fosfomycin trometamol (Monuril). Eur Urol (1987) 1.02
Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology (1996) 1.01
Ethanol metabolism and ethanol-drug interactions. Biochem Pharmacol (1976) 1.00
Nigrostriatal innervation is preserved in Nurr1-null mice, although dopaminergic neuron precursors are arrested from terminal differentiation. Brain Res Mol Brain Res (2000) 1.00
Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progeny. Am J Obstet Gynecol (1984) 0.99
Induction of phenobarbital of microsomal mixed oxidase enzymes in regenerating rat liver. J Biol Chem (1970) 0.98
Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy (2011) 0.98
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum Gene Ther (1998) 0.97
Changes in hepatic collagen metabolism in rats produced by chronic ethanol feeding. Lab Invest (1977) 0.97
APOE-dependent PET patterns of brain activation in Alzheimer disease. Neurology (2004) 0.97
Direct stimulation of beta 2-adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo. Proc Natl Acad Sci U S A (1983) 0.97
Clinical Manifestations of Tetryl and Trinitrotoluene. Br Med J (1941) 0.97